Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 115
Selected: 0
NCT IDTitle
NCT02069067Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT01656551MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
NCT02035683PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT04310176Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
NCT07269249Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
NCT06905262Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT06905145Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT07290894Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
NCT05233982MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
NCT04416672Validation of the Italian Version of the PRO-CTCAE
NCT06270602The ONCOCAMP Study
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT05821556Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
NCT06884878Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
NCT07175350Financial Toxicity (FT) for Radiotherapy (RT) Patients in Italy: a yAIRO (Associazione Italiana Radioterapia e Ocologia Clinica) Multicenter Study
NCT07213557Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy
NCT06218511A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
NCT00401635END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
NCT03410784Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT00331097ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
NCT07267780Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.
NCT04397601Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
NCT00526643CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT04122911Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
NCT02624128Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
NCT01706120Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
NCT03203005IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT00660842Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT01628211Second Look Laparoscopy in Colorectal Cancer
NCT03874026Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
NCT00401674MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT04123925Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study
NCT06866093The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT00526396STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
NCT00401492MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
NCT04317092Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
NCT06714357ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT00403429MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
NCT04893356Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT01074684Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01651013Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
NCT06032975PRO for Fighting FT in Ovarian Cancer
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval